Implantation of Decellularized Small‐caliber Vascular Xenografts With and Without Surface Heparin Treatment
Authors:
- 12 February 2007
- journal article
- research article
- Published by Wiley in Artificial Organs
- Vol. 31 (2) , 99-104
Abstract
Abstract: Heparin treatment of decellularized xenografts has been reported to reduce graft thrombogenicity. However, little is known about the in vivo comparison of heparin‐treated with non‐heparin‐treated xenografts, especially for small‐caliber vascular implants. We implanted either a heparin‐treated or a non‐heparin‐treated canine carotid artery as bilateral carotid xenograft in rabbits (n = 24). Small‐caliber xenografts (3∼4 mm) were decellularized by enzymatic and detergent extraction and were further covalently linked with heparin. During implantation, thrombosis rate was 4% in the heparin‐treated xenografts and 25% in the non‐heparin‐treated xenografts after 3 weeks (P < 0.05). After 6 months, it was 8 versus 58%, respectively (P < 0.01). Both heparin‐treated and non‐heparin‐treated xenografts harvested at the end of 3 and 6 months showed a satisfactory cellular reconstruction of either smooth muscle cells or endothelial cells. These results indicate that heparin treatment of the small‐caliber decellularized xenograft reduces the in vivo thrombogenicity. Both heparin‐treated and non‐heparin‐treated xenografts seem to undergo a similar cellular remodeling process up to 6 months.Keywords
This publication has 25 references indexed in Scilit:
- Heparin-Binding Domains in Vascular BiologyArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Decellularized vein as a potential scaffold for vascular tissue engineeringJournal of Vascular Surgery, 2004
- Basic Fibroblast Growth Factor Coating and Endothelial Cell Seeding of a Decellularized Heparin‐coated Vascular GraftArtificial Organs, 2004
- Acellular Scaffold Implantation – No Alternative to Tissue EngineeringThe International Journal of Artificial Organs, 2003
- Biomaterials in the development and future of vascular graftsJournal of Vascular Surgery, 2003
- Evaluation of a Xenogeneic Acellular Collagen Matrix as a Small-Diameter Vascular Graft in Dogs-Preliminary ObservationsJournal of Investigative Surgery, 2001
- The consequences of a failed femoropopliteal bypass grafting: Comparison of saphenous vein and PTFE graftsJournal of Vascular Surgery, 2000
- Tissue Engineering of Vascular Grafts: Human Cell Seeding of Decellularised Porcine MatrixEuropean Journal of Vascular and Endovascular Surgery, 2000
- New alternative coronary bypass graft: First clinical experience with an autologous endothelialized cryopreserved allograftThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Acellular matrix: A biomaterials approach for coronary artery bypass and heart valve replacementThe Annals of Thoracic Surgery, 1995